agence france-presse
click here to return to agence france-presse main menu
DonateNow



New study pinpoints HIV risk within existing African couples

Agence France-Presse - June 27, 2008


PARIS, June 27, 2008 (AFP) - HIV infections among heterosexual Africans could be slashed by more than a third if safe-sex counselling was directed at married or cohabiting couples, a new study says.

The investigation, published in Saturday's issue of the British medical weekly The Lancet, probed the rate of new HIV infections among 2,279 Zambians and 1,782 Rwandans living in towns.

Between 55.1 percent and 92.7 percent of new infections occurred among "serodiscordant" marital or cohabiting couples, it found.

"Serodiscordant" means that, at the start of the study, one partner in a couple had the human immunodeficiency virus (HIV) but the other partner did not.

The finding provides statistical ammunition for those who argue that, in Africa, established relationships are a huge vector for spreading the AIDS virus.

By targeting these couples with voluntary advice about safe sex and encouragement to get an HIV test, health watchdogs could avert between 36 and 60 percent of heterosexually-transmitted HIV infections that would otherwise occur, the paper says.

Lead author is Kristin Dunkle of the Rollins School of Public Health at Emory University in Atlanta, Georgia.

Around 33 million people around the world are infected with the human immunodeficiency virus (HIV) that causes AIDS, according to the agency UNAIDS. Two-thirds of them are living in sub-Saharan Africa.

Previous research in this field suggests that, for African women, the greatest risk of contracting HIV lies within marriage, but few attempts have been made to determine a man's risk within a marital relationship.

Ignorance about one's HIV status and infections from casual sex outside the couple are the major drivers.

080627
AF080624


Copyright ©AFP 2008. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics.  http://www.afp.com/

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.